Prion infection correlates with hypersensitivity of P2X7 nucleotide receptor in a mouse microglial cell line

FEBS Letters

Volumn 581, Issue 16, 2007, Pages 3019-3026

  Takenouchi, Takato ^a   Iwamaru, Yoshifumi ^b   Imamura, Morikazu ^b   Kato, Nobuko ^b   Sugama, Shuei ^c,d   Fujita, Masayo ^d   Hashimoto, Makoto ^d   Sato, Mitsuru ^a   Okada, Hiroyuki ^b   Yokoyama, Takashi ^b   Mohri, Shirou ^b   Kitani, Hiroshi ^a  

^a NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

Author keywords

ATP; Cytosolic calcium; Microglia; P2X7 receptor; Prion

Indexed keywords

INTERLEUKIN 1BETA; PENTOSAN POLYSULFATE; PRION PROTEIN; PURINE P2X7 RECEPTOR; PURINERGIC RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ARTICLE; BRAIN TISSUE; CALCIUM TRANSPORT; CELL CULTURE; CELL DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; HYPERSENSITIVITY; INFECTION; MEMBRANE FORMATION; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRION DISEASE; PRIORITY JOURNAL; PROTEIN SECRETION; UPREGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM SIGNALING; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MICE; MICE, INBRED STRAINS; MICROGLIA; PENTOSAN SULFURIC POLYESTER; PRIONS; RECEPTORS, PURINERGIC P2; SCRAPIE;

MUS;

EID: 34250174806     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.05.057     Document Type: Article

References (42)

1. Brown A.R., Webb J., Rebus S., Walker R., Williams A., and Fazakerley J.K. Inducible cytokine gene expression in the brain in the ME7/CV mouse model of scrapie is highly restricted, is at a strikingly low level relative to the degree of gliosis and occurs only late in disease. J. Gen. Virol. 84 (2003) 2605-2611
2. Scott J.R. Scrapie pathogenesis. Br. Med. Bull. 49 (1993) 778-791
3. Prusiner S.B. Molecular biology of prion diseases. Science 252 (1991) 1515-1522
4. Prusiner S.B., Scott M.R., DeArmond S.J., and Cohen F.E. Prion protein biology. Cell 93 (1998) 337-348
5. Giese A., Brown D.R., Groschup M.H., Feldmann C., Haist I., and Kretzschmar H.A. Role of microglia in neuronal cell death in prion disease. Brain Pathol. 8 (1998) 449-457
6. Marella M., and Chabry J. Neurons and astrocytes respond to prion infection by inducing microglia recruitment. J. Neurosci. 24 (2004) 620-627
7. Guiroy D.C., Wakayama I., Liberski P.P., and Gajdusek D.C. Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Straussler syndrome. Acta Neuropathol. (Berl) 87 (1994) 526-530
8. Williams A., Lucassen P.J., Ritchie D., and Bruce M. PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144 (1997) 433-438
9. Collo G., Neidhart S., Kawashima E., Kosco-Vilbois M., North R.A., and Buell G. Tissue distribution of the P2X7 receptor. Neuropharmacology 36 (1997) 1277-1283
10. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Collo G., Buell G., and Di Virgilio F. ATP-mediated cytotoxicity in microglial cells. Neuropharmacology 36 (1997) 1295-1301
11. Ferrari D., Los M., Bauer M.K., Vandenabeele P., Wesselborg S., and Schulze-Osthoff K. P2Z purinoreceptor ligation induces activation of caspases with distinct roles in apoptotic and necrotic alterations of cell death. FEBS Lett. 447 (1999) 71-75
12. Ferrari D., Villalba M., Chiozzi P., Falzoni S., Ricciardi-Castagnoli P., and Di Virgilio F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol. 156 (1996) 1531-1539
13. Chessell I.P., Michel A.D., and Humphrey P.P. Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121 (1997) 1429-1437
14. Sanz J.M., and Di Virgilio F. Kinetics and mechanism of ATP-dependent IL-1β release from microglial cells. J. Immunol. 164 (2000) 4893-4898
15. 2+ influx and pore formation induced by the activation of P2X7 nucleotide receptors in mouse microglial cell line. Biochim. Biophys. Acta 1726 (2005) 177-186
16. McLarnon J.G., Ryu J.K., Walker D.G., and Choi H.B. Upregulated expression of purinergic P2X7 receptor in Alzheimer disease and amyloid-β peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol. 65 (2006) 1090-1097
17. Parvathenani L.K., Tertyshnikova S., Greco C.R., Roberts S.B., Robertson B., and Posmantur R. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem. 278 (2003) 13309-13317
18. Franke H., et al. P2X7 receptor expression after ischemia in the cerebral cortex of rats. J. Neuropathol. Exp. Neurol. 63 (2004) 686-699
19. Wirkner K., et al. Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. J. Neurochem. 95 (2005) 1421-1437
20. Hanisch U.K. Microglia as a source and target of cytokines. Glia 40 (2002) 140-155
21. Iwamaru Y., et al. Microglial cell line established from prion protein overexpressing mice is susceptible to various murine prion strains. J. Virol. 81 (2007) 1524-1527
22. 2+ concentration in PC12h cells: effect of tachykinin peptides. Neurosci. Lett. 246 (1998) 141-144
23. 2+ influx in PC12h cells in culture. Neurosci. Lett. 173 (1994) 147-150
24. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
25. Livak, K. (1997). Standard curve method. ABI Prism 7700 Sequence Detection System, User Bulletin 2, PE Applied Biosystems, 3-9.
26. Hayashi H.K., Yokoyama T., Takata M., Iwamaru Y., Imamura M., Ushiki Y.K., and Shinagawa M. The N-terminal cleavage site of PrPSc from BSE differs from that of PrPSc from scrapie. Biochem. Biophys. Res. Commun. 328 (2005) 1024-1027
27. 2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J. Neurochem. (2007) 10.1111/j.1471-4159.2007.04570.x
28. North R.A. Molecular physiology of P2X receptors. Physiol. Rev. 82 (2002) 1013-1067
29. Jiang L.H., Mackenzie A.B., North R.A., and Surprenant A. Brilliant blue G selectively blocks ATP-gated rat P2X(7) receptors. Mol. Pharmacol. 58 (2000) 82-88
30. Virginio C., Church D., North R.A., and Surprenant A. Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology 36 (1997) 1285-1294
31. Takenouchi T., and Munekata E. Trophic effects of substance P and β-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells. Life Sci. 56 (1995) PL479-PL484
32. Caughey B., and Raymond G.J. Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J. Virol. 67 (1993) 643-650
33. Ostlund P., Lindegren H., Pettersson C., and Bedecs K. Up-regulation of functionally impaired insulin like growth factor-1 receptor in scrapie-infected neuroblastoma cells. J. Biol. Chem. 276 (2001) 36110-36115
34. Narcisse L., Scemes E., Zhao Y., Lee S.C., and Brosnan C.F. The cytokine IL-1β transiently enhances P2X7 receptor expression and function in human astrocytes. Glia 49 (2005) 245-258
35. Humphreys B.D., and Dubyak G.R. Modulation of P2X7 nucleotide receptor expression by pro- and anti-inflammatory stimuli in THP-1 monocytes. J. Leukoc. Biol. 64 (1998) 265-273
36. Perry V.H., Cunningham C., and Boche D. Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15 (2002) 349-354
37. Lu Z.Y., Baker C.A., and Manuelidis L. New molecular markers of early and progressive CJD brain infection. J. Cell. Biochem. 93 (2004) 644-652
38. Whatley S.A., Powell J.F., Politopoulou G., Campbell I.C., Brammer M.J., and Percy N.S. Regulation of intracellular free calcium levels by the cellular prion protein. Neuroreport 6 (1995) 2333-2337
39. Korte S., Vassallo N., Kramer M.L., Kretzschmar H.A., and Herms J. Modulation of L-type voltage-gated calcium channels by recombinant prion protein. J. Neurochem. 87 (2003) 1037-1042
40. Sandberg M.K., Wallen P., Wikstrom M.A., and Kristensson K. Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Ca(v) 2.2) which is ameliorated by quinacrine treatment. Neurobiol. Dis. 15 (2004) 143-151
41. Shyng S.L., Lehmann S., Moulder K.L., and Harris D.A. Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J. Biol. Chem. 270 (1995) 30221-30229
42. Castilla J., Saa P., and Soto C. Detection of prions in blood. Nat. Med. 11 (2005) 982-985